Runqiu Jiang Selected Research

Biomarkers (Surrogate Marker)

2/2015	Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma.
1/2015	HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Runqiu Jiang Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 06/2006
22	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 03/2010
8	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2006
6	Inflammation (Inflammations) 12/2021 - 09/2011
5	Liver Diseases (Liver Disease) 12/2021 - 11/2014
5	Liver Cirrhosis (Hepatic Cirrhosis) 12/2021 - 08/2013
4	Carcinogenesis 01/2021 - 02/2015
3	Stomach Neoplasms (Stomach Cancer) 03/2024 - 12/2015
3	Fibrosis (Cirrhosis) 04/2021 - 08/2013
3	Liver Neoplasms (Liver Cancer) 04/2015 - 03/2010
2	Nasopharyngeal Carcinoma 05/2024 - 10/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2024 - 02/2013
2	Non-alcoholic Fatty Liver Disease 11/2023 - 01/2017
2	Fatty Liver 11/2023 - 01/2021
2	Chronic Hepatitis (Chronic Active Hepatitis) 08/2013 - 09/2011
1	Ileitis 01/2024
1	Glucose Intolerance 11/2023
1	Body Weight (Weight, Body) 11/2023
1	Dysbiosis 11/2023
1	Pathologic Complete Response 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Alcoholic Fatty Liver 01/2021
1	Insulin Resistance 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Hypercholesterolemia 10/2019
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2019
1	Hepatic Encephalopathy 11/2018
1	Brain Injuries (Brain Injury) 11/2018
1	Liver Failure 11/2018
1	Acute Liver Failure (Fulminant Hepatic Failure) 11/2018
1	End Stage Liver Disease 11/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

8	Bile Acids and Salts (Bile Acids)IBA 01/2024 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 04/2021 - 10/2014
5	Class 3 Receptor-Like Protein Tyrosine PhosphatasesIBA 01/2020 - 02/2013
5	CytokinesIBA 04/2016 - 09/2011
4	VaccinesIBA 01/2022 - 07/2013
4	Long Noncoding RNAIBA 01/2021 - 02/2015
3	Membrane Proteins (Integral Membrane Proteins)IBA 05/2024 - 01/2011
3	LipidsIBA 11/2023 - 10/2019
3	Interleukin-22 (IL-22)IBA 01/2021 - 09/2011
2	Neoplasm Antigens (Tumor Antigens)IBA 05/2024 - 10/2014
2	Sirolimus (Rapamycin)FDA Link 05/2024 - 10/2014
2	Protein Isoforms (Isoforms)IBA 01/2020 - 08/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 09/2011
2	Streptozocin (Streptozotocin)FDA Link 11/2018 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 02/2015 - 01/2015
2	Interleukin-17 (Interleukin 17)IBA 08/2013 - 02/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 09/2011
2	Estrogens (Estrogen)FDA Link 02/2013 - 09/2011
1	Dextran SulfateIBA 01/2024
1	Interleukin-10 (Interleukin 10)IBA 01/2024
1	FructoseIBA 11/2023
1	venetoclaxIBA 01/2022
1	PeroxiredoxinsIBA 12/2021
1	Carrier Proteins (Binding Protein)IBA 12/2021
1	Guanine NucleotidesIBA 12/2021
1	p38 Mitogen-Activated Protein KinasesIBA 04/2021
1	Glycodeoxycholic AcidIBA 04/2021
1	Taurodeoxycholic AcidIBA 04/2021
1	PhytochemicalsIBA 01/2021
1	ChromatinIBA 01/2021
1	6-methyladenineIBA 01/2021
1	N-methyladenosineIBA 01/2021
1	FatsIBA 01/2021
1	muricholic acidIBA 01/2021
1	GlucosinolatesIBA 01/2021
1	LuciferasesIBA 01/2021
1	interleukin-22 receptor (IL-22R)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 11/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	KinesinsIBA 10/2020
1	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 10/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Versicans (Versican)IBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	theabrowninIBA 10/2019
1	CholesterolIBA 10/2019
1	TeaIBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2019
1	Circular RNAIBA 10/2019
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2019
1	AzoxymethaneIBA 11/2018
1	AmmoniaIBA 11/2018
1	SodiumIBA 11/2018
1	1- (4- (4- (3,3- dibutyl- 7- (dimethylamino)- 2,3,4,5- tetrahydro- 4- hydroxy- 1,1- dioxido- 1- benzothiepin- 5- yl)phenoxy)butyl)- 4- aza- 1- azoniabicyclo(2.2.2)octaneIBA 11/2018
1	Interleukin-33IBA 04/2018
1	salicylhydroxamic acid (SHAM)IBA 04/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	Cholestyramine Resin (Questran)FDA LinkGeneric 01/2017

Therapy/Procedure

8	Therapeutics 03/2024 - 03/2010
4	Transplantation 01/2024 - 09/2011
3	Immunotherapy 11/2023 - 04/2015
1	Fecal Microbiota Transplantation 01/2024
1	Aftercare (After-Treatment) 01/2022
1	Ligation 04/2018